{
    "ticker": "QNRX",
    "name": "Quoin Pharmaceuticals Ltd.",
    "description": "Quoin Pharmaceuticals Ltd. is a biopharmaceutical company focused on developing and commercializing innovative treatments for rare and specialty diseases. Founded in 2017, Quoin's mission is to address unmet medical needs by leveraging its proprietary drug delivery technologies and expertise in pharmaceutical development. The company primarily targets conditions such as rare metabolic disorders and dermatological diseases, aiming to offer new therapeutic options that improve patient outcomes. Quoin is known for its lead product candidate, which is being developed to treat a rare genetic disorder, and it is actively engaged in clinical trials to demonstrate the efficacy and safety of its therapies. By combining scientific innovation with a patient-centric approach, Quoin seeks to transform the treatment landscape for patients suffering from complex and often overlooked conditions. The company is also committed to sustainability and ethical practices in drug development, ensuring that its operations benefit both patients and the environment.",
    "industry": [
        "Biopharmaceuticals",
        "Healthcare"
    ],
    "headquarters": "San Diego, California, USA",
    "founded": "2017",
    "website": "https://www.quoinpharma.com",
    "ceo": "Dr. Michael A. D. W. McGowan",
    "social_media": {
        "twitter": "https://twitter.com/quoinpharma",
        "linkedin": "https://www.linkedin.com/company/quoin-pharmaceuticals-ltd/"
    },
    "investor_relations": "https://www.quoinpharma.com/investors",
    "key_executives": [
        {
            "name": "Dr. Michael A. D. W. McGowan",
            "position": "CEO"
        },
        {
            "name": "David S. H. Yang",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Pharmaceuticals",
            "products": [
                "Lead Product Candidate"
            ]
        }
    ],
    "seo": {
        "meta_title": "Quoin Pharmaceuticals Ltd. | Innovating Rare Disease Treatments",
        "meta_description": "Explore Quoin Pharmaceuticals Ltd., a biopharmaceutical company dedicated to developing treatments for rare and specialty diseases. Learn about our innovative approach and product pipeline.",
        "keywords": [
            "Quoin Pharmaceuticals",
            "Biopharmaceuticals",
            "Rare Diseases",
            "Healthcare Innovation",
            "Drug Development"
        ]
    },
    "faq": [
        {
            "question": "What does Quoin Pharmaceuticals specialize in?",
            "answer": "Quoin Pharmaceuticals specializes in developing treatments for rare and specialty diseases."
        },
        {
            "question": "Who is the CEO of Quoin Pharmaceuticals?",
            "answer": "Dr. Michael A. D. W. McGowan is the CEO of Quoin Pharmaceuticals Ltd."
        },
        {
            "question": "Where is Quoin Pharmaceuticals headquartered?",
            "answer": "Quoin Pharmaceuticals is headquartered in San Diego, California, USA."
        },
        {
            "question": "What is Quoin's lead product candidate?",
            "answer": "Quoin's lead product candidate is being developed to treat a rare genetic disorder."
        },
        {
            "question": "When was Quoin Pharmaceuticals founded?",
            "answer": "Quoin Pharmaceuticals was founded in 2017."
        }
    ],
    "competitors": [
        "RARE",
        "ACAD",
        "SGEN",
        "BMRN"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "REGN",
        "VRTX"
    ]
}